PD-L2 is expressed on activated human T cells and regulates their function

被引:98
|
作者
Messal, Nassima [1 ,2 ,3 ]
Serriari, Nacer-Eddine [1 ,2 ,3 ]
Pastor, Sonia [1 ,2 ,3 ]
Nunes, Jacques A. [1 ,2 ,3 ]
Olive, Daniel [1 ,2 ,3 ]
机构
[1] Ctr Rech Cancerol Marseille, Inst Natl Sante & Rech Med, U891, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, F-13009 Marseille, France
[3] Univ Mediterranee, F-13009 Marseille, France
关键词
T cells; Cell activation; Costimulatory molecules; PD-L2; B7; LIGANDS; SUSCEPTIBILITY; INFECTION; RESPONSES;
D O I
10.1016/j.molimm.2011.06.436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T-cell activation and proliferation are regulated by cosignaling adhesion molecules involved in positive or negative signals. Programmed death (PD)-1 is one of immune inhibitory molecules that is expressed in activated T cells and is a promising target for immunotherapy. Both PD-1 ligands, PD-L1 and PD-L2 are expressed on antigen presenting cells (APCs) involved in the dialogue between a T cell and an APC. Here, we analysed the expression of these ligands, especially for PD-L2, on T cells. PD-L2 appears to be expressed on activated CD4 and CD8T cell subsets. Moreover, as PD-1 molecule, PD-L2 engagement at the surface of T cells is able to down-modulate cytokine production and cell proliferation. These observations indicate that PD-L2 is expressed following activation and is involved in the regulation of T cell function, highlighting the level of complexity in the T cell cosignaling network. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2214 / 2219
页数:6
相关论文
共 50 条
  • [41] Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ
    Olive, Daniel
    Kieu Suong Le
    Roussel, Mikael
    Broussais, Florence
    Azzaoui, Imane
    Rossille, Delphine
    Bouabdallah, Reda
    Fest, Thierry
    Xerri, Luc
    Lamy, Thierry
    Pangault, Celine
    BLOOD, 2014, 124 (21)
  • [42] PD-L1 and PD-L2 expression in colorectal cancer
    Zeynep, Ozgul
    Funda, Canaz
    Evrim, Yilmaz
    Deniz, Arik
    Bulent, Yildiz
    Fatih, Yasar. N.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (01) : 31 - 37
  • [43] The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
    Chaib, Selim
    Lopez-Dominguez, Jose Alberto
    Lalinde-Gutierrez, Marta
    Prats, Neus
    Marin, Ines
    Boix, Olga
    Garcia-Garijo, Andrea
    Meyer, Kathleen
    Munoz, Maria Isabel
    Aguilera, Monica
    Mateo, Lidia
    Attolini, Camille Stephan-Otto
    Llanos, Susana
    Perez-Ramos, Sandra
    Escorihuela, Marta
    Al-Shahrour, Fatima
    Cash, Timothy P.
    Tchkonia, Tamara
    Kirkland, James L.
    Abad, Maria
    Gros, Alena
    Arribas, Joaquin
    Serrano, Manuel
    NATURE CANCER, 2024, 5 (03) : 448 - 462
  • [44] Impact of radio(chemo)therapy on expression of immune checkpoint ligands PD-L1 and PD-L2 on murine and human melanoma cells
    Riegel, D.
    Baeumler, M.
    Spiljar, M.
    Rueckert, M.
    Frey, B.
    Fietkau, R.
    Derer, A.
    Gaipl, U. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S132 - S132
  • [45] The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
    Selim Chaib
    José Alberto López-Domínguez
    Marta Lalinde-Gutiérrez
    Neus Prats
    Ines Marin
    Olga Boix
    Andrea García-Garijo
    Kathleen Meyer
    María Isabel Muñoz
    Mònica Aguilera
    Lidia Mateo
    Camille Stephan-Otto Attolini
    Susana Llanos
    Sandra Pérez-Ramos
    Marta Escorihuela
    Fatima Al-Shahrour
    Timothy P. Cash
    Tamara Tchkonia
    James L. Kirkland
    María Abad
    Alena Gros
    Joaquín Arribas
    Manuel Serrano
    Nature Cancer, 2024, 5 : 448 - 462
  • [46] Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2
    Huber, Silke
    Hoffmann, Reinhard
    Muskens, Femke
    Voehringer, David
    BLOOD, 2010, 116 (17) : 3311 - 3320
  • [47] PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
    Menguy, Sarah
    Prochazkova-Carlotti, Martina
    Beylot-Barry, Marie
    Saltel, Frederic
    Vergier, Beatrice
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (03) : 326 - 334
  • [48] PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
    Loke, P
    Allison, JP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) : 5336 - 5341
  • [49] PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
    Yearley, Jennifer H.
    Gibson, Christopher
    Yu, Ni
    Moon, Christina
    Murphy, Erin
    Juco, Jonathan
    Lunceford, Jared
    Cheng, Jonathan
    Chow, Laura Q. M.
    Seiwert, Tanguy Y.
    Handa, Masahisa
    Tomassini, Joanne E.
    McClanahan, Terrill
    CLINICAL CANCER RESEARCH, 2017, 23 (12) : 3158 - 3167
  • [50] Single Cell Analysis Identifies Expression of PD-L2 on Human Bone Marrow Hematopoietic Stem Cells
    Schmachtel, Tessa
    Kuelp, Marius
    Yu, Weijia
    Komic, Hana
    Simoes, Catia
    Nilsson, Malin S.
    Prosper, Felipe
    Schroeder, Timm
    Bonig, Halvard
    Paiva, Bruno
    Thoren, Fredrik B.
    Rieger, Michael A.
    BLOOD, 2023, 142